Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars

Inclusion Criteria:

1. Participants of both sexes aged between 18 and 70 years;

2. Participants with recent scars (<30 days);

3. Participants with phototypes III to VI according to the Fitzpatrick scale;

4. Agree to follow the trial procedures and attend the center on the days and timesdetermined for evaluations;

5. Understand, agree to and sign the free and informed consent form.

6. Types of scars: cesarean section, breast implant or blunt cut injury.

Exclusion Criteria:

1. Pregnancy or risk of pregnancy;

2. History of atopic or allergic reactions to cosmetic products;

3. Participants who are using topical antibiotics or other skin products on the samearea being evaluated;

4. Immunosuppression due to drugs or active diseases;

5. Decompensated endocrine diseases;

6. Relevant clinical history or current evidence of alcohol or other drug abuse;

7. Known history or suspected intolerance to products in the same category;

8. Intense sun exposure up to 15 days before the evaluation;

9. Patients who are using topical antibiotics or other skin products on the same areabeing evaluated.